|
67
|
275
|
2f74A |
Murine mhc class i h-2db in complex with human b2-microglobulin and lcmv-derived immunodminant peptide gp33 |
|
67
|
274
|
2f54A |
Directed evolution of human t cell receptor cdr2 residues by phage display dramatically enhances affinity for cognate peptide-mhc without increasing apparent cross-reactivity |
|
67
|
275
|
2esvA |
Structure of the hla-e-vmaprtlil/kk50.4 tcr complex |
|
74
|
275
|
2dypA |
Crystal structure of lilrb2(lir2/ilt4/cd85d) complexed with hla-g |
|
63
|
274
|
2d31A |
Crystal structure of disulfide-linked hla-g dimer |
|
72
|
278
|
2clvA |
Mhc class i natural mutant h-2kbm8 heavy chain complexed with beta-2 microglobulin and pbm8 peptide |
|
76
|
276
|
2cikA |
Insights into crossreactivity in human allorecognition: the structure of hla-b35011 presenting an epitope derived from cytochrome p450. |
|
71
|
275
|
2clrA |
Three dimensional structure of a peptide extending out one end of a class i mhc binding site |
|
69
|
278
|
2clzA |
Mhc class i natural mutant h-2kbm8 heavy chain complexed with beta-2 microglobulin and pbm1 peptide |
|
68
|
275
|
2ciiA |
The crystal structure of h-2db complexed with a partial peptide epitope suggests an mhc class i assembly-intermediate |
|
61
|
274
|
2ckbH |
Structure of the 2c/kb/dev8 complex |
|
67
|
275
|
2c7uA |
Conflicting selective forces affect cd8 t-cell receptor contact sites in an hla-a2 immunodominant hiv epitope. |
|
76
|
276
|
2bssA |
Crystal structures and kir3dl1 recognition of three immunodominant viral peptides complexed to hla-b2705 |
|
74
|
276
|
2bnrA |
Structural and kinetic basis for heightened immunogenicity of t cell vaccines |
|
76
|
276
|
2bnqA |
Structural and kinetic basis for heightened immunogenicity of t cell vaccines |
|
76
|
274
|
2bvoA |
Structures of three hiv-1 hla-b5703-peptide complexes and identification of related hlas potentially associated with long-term non-progression |
|
76
|
274
|
2bvpA |
Structures of three hiv-1 hla-b5703-peptide complexes and identification of related hlas potentially associated with long-term non-progression |
|
74
|
276
|
2bsrA |
Crystal structures and kir3dl1 recognition of three immunodominant viral peptides complexed to hla-b2705 |
|
73
|
276
|
2bstA |
Crystal structures and kir3dl1 recognition of three immunodominant viral peptides complexed to hla-b2705 |
|
76
|
286
|
2bckA |
Crystal structure of hla-a*2402 complexed with a telomerase peptide |
|
76
|
274
|
2bvqA |
Structures of three hiv-1 hla-b5703-peptide complexes and identification of related hlas potentially associated with long-term non-progression |
|
76
|
275
|
2av7A |
Crystal structure of htlv-1 tax peptide bound to human class i mhc hla-a2 with the k66a mutation in the heavy chain. |
|
82
|
276
|
2axfA |
The immunogenicity of a viral cytotoxic t cell epitope is controlled by its mhc-bound conformation |
|
78
|
276
|
2ak4A |
Crystal structure of sb27 tcr in complex with hla-b*3508-13mer peptide |
|
77
|
276
|
2axgA |
The immunogenicity of a viral cytotoxic t cell epitope is controlled by its mhc-bound conformation |
|
75
|
275
|
2av1A |
Crystal structure of htlv-1 tax peptide bound to human class i mhc hla-a2 with the e63q and k66a mutations in the heavy chain. |
|
80
|
273
|
2akrA |
Structural basis of sulfatide presentation by mouse cd1d |
|
62
|
275
|
1zt7A |
Crystal structure of class i mhc h-2kk in complex with a nonapeptide |
|
67
|
277
|
1zt1A |
Crystal structure of class i mhc h-2kk in complex with an octapeptide |
|
67
|
278
|
1zvsA |
Crystal structure of the first class mhc mamu and tat-tl8 complex |
|
60
|
274
|
1zs8A |
Crystal structure of the murine mhc class ib molecule m10.5 |
|
75
|
273
|
1zagA |
Human zinc-alpha-2-glycoprotein |
|
75
|
276
|
1zhkA |
Crystal structure of hla-b*3501 presenting 13-mer ebv antigen lpeplpqgqltay |
|
77
|
276
|
1zsdA |
Crystal structure of hla-b*3501 presenting an 11-mer ebv antigen eplpqgqltay |
|
72
|
273
|
1zhnA |
Crystal structure of mouse cd1d bound to the self ligand phosphatidylcholine |
|
78
|
276
|
2a83A |
Crystal structure of hla-b*2705 complexed with the glucagon receptor (gr) peptide (residues 412-420) |
|
68
|
272
|
1zt4A |
The crystal structure of human cd1d with and without alpha-galactosylceramide |
|
78
|
276
|
1zhlA |
Crystal structure of hla-b*3508 presenting 13-mer ebv antigen lpeplpqgqltay |
|
63
|
273
|
1zhbA |
Crystal structure of the murine class i major histocompatibility complex of h-2db, b2-microglobulin, and a 9-residue peptide derived from rat dopamine beta-monooxigenase |
|
71
|
272
|
1z5lA |
Structure of a highly potent short-chain galactosyl ceramide agonist bound to cd1d |
|
78
|
275
|
1ydpA |
1.9a crystal structure of hla-g |
|
48
|
260
|
1ypzA |
Immune receptor |
|
67
|
273
|
1yn7A |
Crystal structure of a mouse mhc class i protein, h2-db, in complex with a mutated peptide (r7a) of the influenza a acid polymerase |
|
68
|
271
|
1xz0A |
Crystal structure of cd1a in complex with a synthetic mycobactin lipopeptide |
|
71
|
273
|
1yn6A |
Crystal structure of a mouse mhc class i protein, h2-db, in complex with a peptide from the influenza a acid polymerase |
|
78
|
276
|
1xr9A |
Crystal structures of hla-b*1501 in complex with peptides from human ubch6 and epstein-barr virus ebna-3 |
|
80
|
276
|
1xh3A |
Conformational restraints and flexibility of 14-meric peptides in complex with hla-b*3501 |
|
76
|
276
|
1xr8A |
Crystal structures of hla-b*1501 in complex with peptides from human ubch6 and epstein-barr virus ebna-3 |
|
81
|
275
|
1x7qA |
Crystal structure of hla-a*1101 with sars nucleocapsid peptide |
|
75
|
276
|
1w0wA |
Crystal structure of hla-b*2709 complexed with the self-peptide tis from egf-response factor 1 |
